Sep 27, 2023
Join InpharmD as we discuss the safety and efficacy of two FDA-approved RSV vaccines, Arexvy and Abrysvo.
Jul 20, 2023
Join us as we discuss the data surrounding newly approved antifungal agent, rezafungin. Interested in learning more? Join our CE on rezafungin on July 27th at 12:00 PM EST - open to all pharmacists!
Apr 17, 2023
Every month, InpharmD creates a continuing-education (CE) class on the most commonly asked drug information question and the related evidence. Our podcast offers a sneak peak into our CE as we briefly discuss the topic.
Episode-2 looks at the safety and efficacy of lecanemab in the treatment of Alzheimer’s...
Mar 6, 2023
Join us as we discuss the evidence surrounding tirzepatide for weight loss in diabetic patient populations.